Literature DB >> 25778618

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.

Kurt A Jellinger1, Irina Alafuzoff, Johannes Attems, Thomas G Beach, Nigel J Cairns, John F Crary, Dennis W Dickson, Patrick R Hof, Bradley T Hyman, Clifford R Jack, Gregory A Jicha, David S Knopman, Gabor G Kovacs, Ian R Mackenzie, Eliezer Masliah, Thomas J Montine, Peter T Nelson, Frederick Schmitt, Julie A Schneider, Albert Serrano-Pozo, Dietmar R Thal, Jonathan B Toledo, John Q Trojanowski, Juan C Troncoso, Jean Paul Vonsattel, Thomas Wisniewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25778618      PMCID： PMC4534004          DOI： 10.1007/s00401-015-1407-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  55 in total

1.  Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.

Authors:  Stephanie Jb Vos; Chengjie Xiong; Pieter Jelle Visser; Mateusz S Jasielec; Jason Hassenstab; Elizabeth A Grant; Nigel J Cairns; John C Morris; David M Holtzman; Anne M Fagan
Journal:  Lancet Neurol       Date:  2013-09-04       Impact factor: 44.182

2.  The MAPT H1 haplotype is associated with tangle-predominant dementia.

Authors:  Ismael Santa-Maria; Aya Haggiagi; Xinmin Liu; Jessica Wasserscheid; Peter T Nelson; Ken Dewar; Lorraine N Clark; John F Crary
Journal:  Acta Neuropathol       Date:  2012-07-17       Impact factor: 17.088

3.  The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.

Authors:  Marie Y Davis; C Dirk Keene; Suman Jayadev; Thomas Bird
Journal:  J Huntingtons Dis       Date:  2014

Review 4.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

5.  Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital.

Authors:  C Bouras; P R Hof; P Giannakopoulos; J P Michel; J H Morrison
Journal:  Cereb Cortex       Date:  1994 Mar-Apr       Impact factor: 5.357

6.  Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

7.  Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; Walter A Rocca; David S Knopman; Michelle M Mielke; Val J Lowe; Matthew L Senjem; Jeffrey L Gunter; Gregory M Preboske; Vernon S Pankratz; Prashanthi Vemuri; Ronald C Petersen
Journal:  Lancet Neurol       Date:  2014-09-04       Impact factor: 44.182

8.  Neuropathology and general autopsy findings in nondemented aged subjects.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Clin Neuropathol       Date:  2012 Mar-Apr       Impact factor: 1.368

9.  Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.

Authors:  Dietmar Rudolf Thal; Christine A F von Arnim; W Sue T Griffin; Robert E Mrak; Lauren Walker; Johannes Attems; Thomas Arzberger
Journal:  J Neural Transm (Vienna)       Date:  2015-01-04       Impact factor: 3.575

Review 10.  Tau aggregation and its interplay with amyloid-β.

Authors:  Rebecca M Nisbet; Juan-Carlos Polanco; Lars M Ittner; Jürgen Götz
Journal:  Acta Neuropathol       Date:  2014-12-10       Impact factor: 17.088
View more
  69 in total

1.  Association of APOE with tau-tangle pathology with and without β-amyloid.

Authors:  Jose M Farfel; Lei Yu; Philip L De Jager; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-09-28       Impact factor: 4.673

2.  Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.

Authors:  Jon B Toledo; Henrik Zetterberg; Argonde C van Harten; Lidia Glodzik; Pablo Martinez-Lage; Luisella Bocchio-Chiavetto; Lorena Rami; Oskar Hansson; Reisa Sperling; Sebastiaan Engelborghs; Ricardo S Osorio; Hugo Vanderstichele; Manu Vandijck; Harald Hampel; Stefan Teipl; Abhay Moghekar; Marilyn Albert; William T Hu; Jose A Monge Argilés; Ana Gorostidi; Charlotte E Teunissen; Peter P De Deyn; Bradley T Hyman; Jose L Molinuevo; Giovanni B Frisoni; Gurutz Linazasoro; Mony J de Leon; Wiesje M van der Flier; Philip Scheltens; Kaj Blennow; Leslie M Shaw; John Q Trojanowski
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

Review 3.  Suspected non-Alzheimer disease pathophysiology--concept and controversy.

Authors:  Clifford R Jack; David S Knopman; Gaël Chételat; Dennis Dickson; Anne M Fagan; Giovanni B Frisoni; William Jagust; Elizabeth C Mormino; Ronald C Petersen; Reisa A Sperling; Wiesje M van der Flier; Victor L Villemagne; Pieter J Visser; Stephanie J B Vos
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

4.  Cognitive decline associated with pathological burden in primary age-related tauopathy.

Authors:  Kyra S Jefferson-George; David A Wolk; Edward B Lee; Corey T McMillan
Journal:  Alzheimers Dement       Date:  2017-03-16       Impact factor: 21.566

5.  Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis.

Authors:  Matthew D Cykowski; Suzanne Z Powell; Paul E Schulz; Hidehiro Takei; Andreana L Rivera; Robert E Jackson; Gustavo Roman; Gregory A Jicha; Peter T Nelson
Journal:  Arch Pathol Lab Med       Date:  2017-05-03       Impact factor: 5.534

6.  Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease.

Authors:  W Robert Bell; Yang An; Yusuke Kageyama; Collin English; Gay L Rudow; Olga Pletnikova; Madhav Thambisetty; Richard O'Brien; Abhay R Moghekar; Marilyn S Albert; Peter V Rabins; Susan M Resnick; Juan C Troncoso
Journal:  Alzheimers Dement       Date:  2018-12-11       Impact factor: 21.566

7.  Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; David S Knopman; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell; Dennis W Dickson
Journal:  Alzheimers Dement       Date:  2019-05-02       Impact factor: 21.566

Review 8.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

Review 9.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 10.  Developing therapeutic vaccines against Alzheimer's disease.

Authors:  Thomas Wisniewski; Eleanor Drummond
Journal:  Expert Rev Vaccines       Date:  2015-12-11       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.